{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:47:37Z","timestamp":1787237257822,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Thessaly Central Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psoriasis is an inflammation of the skin mediated via the IL-23\/Thl17\/IL-17 pathway. We have previously demonstrated that the anthocyanin delphinidin diminishes in vitro the IL-17 and IFN-\u03b3 production of peripheral monocytes isolated by psoriasis patients (PBMCs). The degradation product of delphinidin is gallic acid (GA). This phenolic acid compound found in fruits, red wine, or green tea exerts pleiotropic antioxidant, anticarcinogenic, antimicrobial, and anti-inflammatory properties. Previous research has demonstrated the inhibitory effect of GA on pro-inflammatory transcription factors, such as STAT3, ROR\u03b3t, and NF-\u03baB, or cytokines as IL-1\u03b2 and TNF, which contribute to psoriasis development. We investigated the effect of GA in vitro on PBMCs, which were stimulated ex vivo, from 40 individuals (28 diagnosed with psoriasis vulgaris and 12 healthy controls (HCs)). In our experiments, PBMCs were cultured untreated or were activated in the presence of phorbol 12-myristate 13-acetate\/ionomycin with or without GA. We utilized multicolor flow cytometry to assess the production of inteleukin-17 (IL-17) and interferon-\u03b3 (IFN-\u03b3) in T and NK cells. GA did not alter the fractions of IL-17- or IFN-\u03b3-producing T and IFN-\u03b3-producing NK cells in HCs. However, in psoriasis patients, the effect of GA on that cell population was significant. Specifically, GA decreased the frequency of IL-17-producing cells within the CD3\n                    <jats:sup>+<\/jats:sup>\n                    (T) and CD3\n                    <jats:sup>+<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    (Th) compartment; the frequency of IFN-\u03b3-producing cells within the CD3\n                    <jats:sup>+<\/jats:sup>\n                    , CD3\n                    <jats:sup>+<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    , and CD3\n                    <jats:sup>+<\/jats:sup>\n                    CD4\n                    <jats:sup>\u2212<\/jats:sup>\n                    (Tc) compartment, and the frequency of IFN-\u03b3-producing cells within the CD3\n                    <jats:sup>\u2212<\/jats:sup>\n                    CD56\n                    <jats:sup>+<\/jats:sup>\n                    (NK) compartment. Whether GA\u2019s effect also appears in vivo needs to be investigated in future.\n                  <\/jats:p>","DOI":"10.1007\/s12026-023-09361-9","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T05:24:33Z","timestamp":1675920273000},"page":"475-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gallic acid diminishes pro-inflammatory interferon-\u03b3- and interleukin-17-producing sub-populations in vitro in patients with psoriasis"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-7281","authenticated-orcid":false,"given":"Sotirios G.","family":"Tsiogkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Apostolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-1323","authenticated-orcid":false,"given":"Athanasios","family":"Mavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-6595","authenticated-orcid":false,"given":"Maria G.","family":"Grammatikopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-641X","authenticated-orcid":false,"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-7292","authenticated-orcid":false,"given":"Efterpi","family":"Zafiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-7902","authenticated-orcid":false,"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"9361_CR1","doi-asserted-by":"crossref","unstructured":"Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the immunopathogenesis of psoriasis [Internet]. Int. J. Mol. Sci. MDPI AG; 2018 [cited 2021 Mar 31]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29316717\/.","DOI":"10.3390\/ijms19010179"},{"key":"9361_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. NF-\u03baB: an essential transcription factor in psoriasis. J Dermatol Sci. 2013;69:89\u201394.","journal-title":"J Dermatol Sci"},{"key":"9361_CR3","doi-asserted-by":"crossref","unstructured":"Tsiogkas SG, Mavropoulos A, Dardiotis E, Zafiriou E, Bogdanos DP. A sharp decrease of Th17, CXCR3 +-Th17 and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis. Clin Exp Immunol. England; 2022.","DOI":"10.1093\/cei\/uxac069"},{"key":"9361_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molimm.2018.11.015","volume":"105","author":"AN Kamali","year":"2019","unstructured":"Kamali AN, Noorbakhsh SM, Hamedifar H, Jadidi-Niaragh F, Yazdani R, Bautista JM, et al. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol Immunol England. 2019;105:107\u201315.","journal-title":"Mol Immunol England"},{"key":"9361_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/jid.2011.458","volume":"132","author":"LM Johnson-Huang","year":"2012","unstructured":"Johnson-Huang LM, Su\u00e1rez-Fari\u00f1as M, Pierson KC, Fuentes-Duculan J, Cueto I, Lentini T, et al. A single intradermal injection of IFN-\u03b3 induces an inflammatory state in both non-lesional psoriatic and healthy skin. J Invest Dermatol. 2012;132:1177\u201387.","journal-title":"J Invest Dermatol"},{"key":"9361_CR6","doi-asserted-by":"crossref","unstructured":"Tsiogkas SG, Mavropoulos \u0391, Skyvalidas DN, Patrikiou E, Ntavari N, Daponte AI, et al. Delphinidin diminishes in vitro interferon-\u03b3 and interleukin-17 producing cells in patients with psoriatic disease. Immunol Res. 2021","DOI":"10.1007\/s12026-021-09251-y"},{"key":"9361_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/1750-3841.14490","volume":"84","author":"KH Hyun","year":"2019","unstructured":"Hyun KH, Gil KC, Kim SG, Park S-Y, Hwang KW. Delphinidin chloride and its hydrolytic metabolite gallic acid promote differentiation of regulatory T cells and have an anti-inflammatory effect on the allograft model. J Food Sci United States. 2019;84:920\u201330.","journal-title":"J Food Sci United States"},{"key":"9361_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/mnfr.200700004","volume":"51","author":"M Kern","year":"2007","unstructured":"Kern M, Fridrich D, Reichert J, Skrbek S, Nussher A, Hofem S, et al. Limited stability in cell culture medium and hydrogen peroxide formation affect the growth inhibitory properties of delphinidin and its degradation product gallic acid. Mol Nutr Food Res. 2007;51:1163\u201372.","journal-title":"Mol Nutr Food Res"},{"key":"9361_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00001","volume":"11","author":"K Yang","year":"2020","unstructured":"Yang K, Zhang L, Liao P, Xiao Z, Zhang F, Sindaye D, et al. Impact of gallic acid on gut health: focus on the gut microbiome, immune response, and mechanisms of action. Front Immunol. 2020;11:1\u201313.","journal-title":"Front Immunol"},{"key":"9361_CR10","doi-asserted-by":"publisher","unstructured":"AL Zahrani NA, El-Shishtawy RM, Asiri AM. Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: a review. Eur J Med Chem [Internet]. Elsevier Masson SAS; 2020;204:112609. Available from: https:\/\/doi.org\/10.1016\/j.ejmech.2020.112609.","DOI":"10.1016\/j.ejmech.2020.112609"},{"key":"9361_CR11","doi-asserted-by":"crossref","unstructured":"Choubey S, Varughese LR ache., Kumar V, Beniwal V. Medicinal importance of gallic acid and its ester derivatives: a patent review. Pharm Pat Anal. 2015;4:305\u201315.","DOI":"10.4155\/ppa.15.14"},{"key":"9361_CR12","doi-asserted-by":"publisher","unstructured":"Kumar N, Goel N. Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol Reports [Internet]. Elsevier B.V.; 2019;24:e00370. Available from: https:\/\/doi.org\/10.1016\/j.btre.2019.e00370.","DOI":"10.1016\/j.btre.2019.e00370"},{"key":"9361_CR13","doi-asserted-by":"publisher","unstructured":"Badhani B, Sharma N, Kakkar R. Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications. RSC Adv [Internet]. Royal Society of Chemistry; 2015;5:27540\u201357. Available from: https:\/\/doi.org\/10.1039\/C5RA01911G.","DOI":"10.1039\/C5RA01911G"},{"key":"9361_CR14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1142\/S0192415X03001648","volume":"31","author":"EJ Cho","year":"2003","unstructured":"Cho EJ, Yokozawa T, Rhyu DY, Kim HY, Shibahara N, Park JC. The inhibitory effects of 12 medicinal plants and their component compounds on lipid peroxidation. Am J Chin Med. 2003;31:907\u201317.","journal-title":"Am J Chin Med"},{"key":"9361_CR15","doi-asserted-by":"publisher","unstructured":"Dhingra MS, Dhingra S, Chadha R, Singh T, Karan M. Design, synthesis, physicochemical, and pharmacological evaluation of gallic acid esters as non-ulcerogenic and gastroprotective anti-inflammatory agents. Med Chem Res [Internet]. 2014;23:4771\u201388. Available from: https:\/\/doi.org\/10.1007\/s00044-014-1041-x.","DOI":"10.1007\/s00044-014-1041-x"},{"key":"9361_CR16","doi-asserted-by":"crossref","unstructured":"Lone SH, Rehman SU, Bhat KA. Synthesis of gallic-acid-1-phenyl-1H-[1,2,3]triazol-4-yl methyl esters as effective antioxidants. Drug Res (Stuttg). Germany; 2017;67:111\u20138.","DOI":"10.1055\/s-0042-118860"},{"key":"9361_CR17","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1021\/jf070473q","volume":"55","author":"N Nenadis","year":"2007","unstructured":"Nenadis N, Lazaridou O, Tsimidou MZ. Use of reference compounds in antioxidant activity assessment. J Agric Food Chem United States. 2007;55:5452\u201360.","journal-title":"J Agric Food Chem United States"},{"key":"9361_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/10715760290006411","volume":"36","author":"K Schlesier","year":"2002","unstructured":"Schlesier K, Harwat M, B\u00f6hm V, Bitsch R. Assessment of antioxidant activity by using different in vitro methods. Free Radic Res England. 2002;36:177\u201387.","journal-title":"Free Radic Res England"},{"key":"9361_CR19","doi-asserted-by":"publisher","unstructured":"Locatelli C, Filippin-Monteiro FB, Creczynski-Pasa TB. Alkyl esters of gallic acid as anticancer agents: A review. Eur J Med Chem [Internet]. Elsevier; 2013;60:233\u20139. Available from: https:\/\/doi.org\/10.1016\/j.ejmech.2012.10.056.","DOI":"10.1016\/j.ejmech.2012.10.056"},{"key":"9361_CR20","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1248\/bpb.18.1526","volume":"18","author":"M Inoue","year":"1995","unstructured":"Inoue M, Suzuki R, Sakaguchi N, Li Z, Takeda T, Ogihara Y, et al. Selective induction of cell death in cancer cells by gallic acid. Biol Pharm Bull Japan. 1995;18:1526\u201330.","journal-title":"Biol Pharm Bull Japan"},{"key":"9361_CR21","doi-asserted-by":"crossref","unstructured":"You BR, Park WH. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol Vitr an Int J Publ Assoc with BIBRA. England; 2010;24:1356\u201362.","DOI":"10.1016\/j.tiv.2010.04.009"},{"key":"9361_CR22","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s11095-009-9926-y","volume":"26","author":"M Kaur","year":"2009","unstructured":"Kaur M, Velmurugan B, Rajamanickam S, Agarwal R, Agarwal C. Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm Res. 2009;26:2133\u201340.","journal-title":"Pharm Res"},{"key":"9361_CR23","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1248\/bpb.23.1153","volume":"23","author":"M Inoue","year":"2000","unstructured":"Inoue M, Sakaguchi N, Isuzugawa K, Tani H, Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull Japan. 2000;23:1153\u20137.","journal-title":"Biol Pharm Bull Japan"},{"key":"9361_CR24","doi-asserted-by":"publisher","unstructured":"Hsiang CY, Hseu YC, Chang YC, Kumar KJS, Ho TY, Yang HL. Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-\u03baB transgenic mice as evaluated by in vivo bioluminescence imaging. Food Chem [Internet]. Elsevier Ltd; 2013;136:426\u201334. Available from: https:\/\/doi.org\/10.1016\/j.foodchem.2012.08.009.","DOI":"10.1016\/j.foodchem.2012.08.009"},{"key":"9361_CR25","first-page":"1","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang R, Li Z, Zou Y, Yang J, Li L, Xu X, et al. Gallic acid alleviates neuropathic pain behaviors in rats by inhibiting P2X7 receptor-mediated NF-\u03baB\/STAT3 signaling pathway. Front Pharmacol. 2021;12:1\u201312.","journal-title":"Front Pharmacol"},{"key":"9361_CR26","doi-asserted-by":"publisher","unstructured":"Fan Y, Piao CH, Hyeon E, Jung SY, Eom JE, Shin HS, et al. Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis. Int Immunopharmacol [Internet]. Elsevier; 2019;70:512\u20139. Available from: https:\/\/doi.org\/10.1016\/j.intimp.2019.02.025.","DOI":"10.1016\/j.intimp.2019.02.025"},{"key":"9361_CR27","doi-asserted-by":"crossref","unstructured":"Cai L, Wei Z, Zhao X, Li Y, Li X, Jiang X. Gallic acid mitigates LPS-induced inflammatory response via suppressing NF-\u03baB signalling pathway in IPEC-J2 cells. J Anim Physiol Anim Nutr (Berl). 2021;1\u20139.","DOI":"10.1111\/jpn.13612"},{"key":"9361_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s10753-020-01319-5","volume":"44","author":"Y Zamudio-Cuevas","year":"2021","unstructured":"Zamudio-Cuevas Y, Andonegui-Elguera MA, Aparicio-Ju\u00e1rez A, Aguill\u00f3n-Sol\u00eds E, Mart\u00ednez-Flores K, Ruvalcaba-Paredes E, et al. The enzymatic poly(gallic acid) reduces pro-inflammatory cytokines in vitro, a potential application in inflammatory diseases. Inflammation Inflammation. 2021;44:174\u201385.","journal-title":"Inflammation Inflammation"},{"key":"9361_CR29","first-page":"1779","volume":"41","author":"T Zhang","year":"2019","unstructured":"Zhang T, Ma L, Wu P, Li W, Li T, Gu R, et al. Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non-small cell lung cancer A549 cells via the JAK\/STAT3 signaling pathway. Oncol Rep. 2019;41:1779\u201388.","journal-title":"Oncol Rep"},{"key":"9361_CR30","doi-asserted-by":"publisher","unstructured":"Zhou G, Kong WS, Li ZC, Xie RF, Yu TY, Zhou X. Effects of Qing Chang suppository powder and its ingredients on IL-17 signal pathway in HT-29 cells and DSS-induced mice. Phytomedicine [Internet]. Elsevier GmbH; 2021;87:153573. Available from: https:\/\/doi.org\/10.1016\/j.phymed.2021.153573.","DOI":"10.1016\/j.phymed.2021.153573"},{"key":"9361_CR31","doi-asserted-by":"publisher","unstructured":"Skyvalidas D, Mavropoulos A, Tsiogkas S, Dardiotis E, Liaskos C, Mamuris Z, et al. Curcumin mediates attenuation of pro-inflammatory interferon \u03b3 and interleukin 17 cytokine responses in psoriatic disease, strengthening its role as a dietary immunosuppressant. Nutr Res [Internet]. Elsevier Inc.; 2020;75:95\u2013108. Available from: https:\/\/doi.org\/10.1016\/j.nutres.2020.01.005.","DOI":"10.1016\/j.nutres.2020.01.005"},{"key":"9361_CR32","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3892\/ol.2013.1632","volume":"6","author":"B Zhao","year":"2013","unstructured":"Zhao B, Hu M. Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells. Oncol Lett Greece. 2013;6:1749\u201355.","journal-title":"Oncol Lett Greece"},{"key":"9361_CR33","doi-asserted-by":"crossref","unstructured":"Yang J-T, Lee I-N, Chen C-H, Lu F-J, Chung C-Y, Lee M-H, et al. Gallic acid enhances the anti-cancer effect of temozolomide in human glioma cell line via inhibition of Akt and p38-MAPK pathway. Processes. 2022.","DOI":"10.3390\/pr10030448"},{"key":"9361_CR34","first-page":"525","volume":"41","author":"ZM Sourani","year":"2016","unstructured":"Sourani ZM, Pourgheysari BP, Beshkar PM, Shirzad HP, Shirzad MM. Gallic acid inhibits proliferation and induces apoptosis in lymphoblastic leukemia cell line (C121). Iran J Med Sci Iran. 2016;41:525\u201330.","journal-title":"Iran J Med Sci Iran"},{"key":"9361_CR35","doi-asserted-by":"crossref","unstructured":"Liang Y, Sarkar MK, Tsoi LC, Gudjonsson JE, Arbor A, Arbor A, et al. Psoriasis: a mixed autoimmune and autoinflammatory disease. 2018;1\u20138.","DOI":"10.1016\/j.coi.2017.07.007"},{"key":"9361_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22062979","volume":"22","author":"N Kanda","year":"2021","unstructured":"Kanda N. Psoriasis: pathogenesis, comorbidities, and therapy updated. Int J Mol Sci. 2021;22:1\u20135.","journal-title":"Int J Mol Sci"},{"key":"9361_CR37","doi-asserted-by":"crossref","unstructured":"Capone A, Volpe E. Transcriptional regulators of T helper 17 cell differentiation in health and autoimmune diseases. Front Immunol. 2020;11.","DOI":"10.3389\/fimmu.2020.00348"},{"key":"9361_CR38","doi-asserted-by":"publisher","unstructured":"Foley JF. STAT3 regulates the generation of Th17 Cells. Sci STKE [Internet]. American Association for the Advancement of Science; 2007;2007:tw113\u2013tw113. Available from: https:\/\/doi.org\/10.1126\/stke.3802007tw113.","DOI":"10.1126\/stke.3802007tw113"},{"key":"9361_CR39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","volume":"90","author":"CT Jordan","year":"2012","unstructured":"Jordan CT, Cao L, Roberson EDO, Duan S, Helms CA, Nair RP, et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am J Hum Genet. 2012;90:796\u2013808.","journal-title":"Am J Hum Genet"},{"key":"9361_CR40","doi-asserted-by":"crossref","unstructured":"Gardiner CM, Dunphy S. NK cells and psoriasis. J Biomed Biotechnol. 2011;2011.","DOI":"10.1155\/2011\/248317"},{"key":"9361_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/eji.200535243","volume":"36","author":"C Ottaviani","year":"2006","unstructured":"Ottaviani C, Nasorri F, Bedini C, de Pit\u00e0 O, Girolomoni G, Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol Germany. 2006;36:118\u201328.","journal-title":"Eur J Immunol Germany"},{"key":"9361_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2133.2004.06168.x","volume":"151","author":"M Kastelan","year":"2004","unstructured":"Kastelan M, Prpi\u0107Massari L, Gruber F, Zamolo G, Zauhar G, Coklo M, et al. Perforin expression is upregulated in the epidermis of psoriatic lesions. Br J Dermatol England. 2004;151:831\u20136.","journal-title":"Br J Dermatol England"},{"key":"9361_CR43","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","volume":"183","author":"WA Goodman","year":"2009","unstructured":"Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol. 2009;183:3170\u20136.","journal-title":"J Immunol"},{"key":"9361_CR44","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol United States. 2007;8:942\u20139.","journal-title":"Nat Immunol United States"},{"key":"9361_CR45","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.3390\/molecules18032483","volume":"18","author":"KYP Liu","year":"2013","unstructured":"Liu KYP, Hu S, Chan BCL, Wat ECL, Lau CBS, Hon KL, et al. Anti-inflammatory and anti-allergic activities of pentaherb formula, moutan cortex (Danpi) and gallic acid. Molecules. 2013;18:2483\u2013500.","journal-title":"Molecules"},{"key":"9361_CR46","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0509736102","volume":"102","author":"MA Lowes","year":"2005","unstructured":"Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin S-L, Nussbaum R, et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci U S A. 2005;102:19057\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9361_CR47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","volume":"131","author":"A Chiricozzi","year":"2011","unstructured":"Chiricozzi A, Guttman-Yassky E, Su\u00e1rez-Fari\u00f1as M, Nograles KE, Tian S, Cardinale I, et al. Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol United States. 2011;131:677\u201387.","journal-title":"J Invest Dermatol United States"},{"key":"9361_CR48","doi-asserted-by":"publisher","unstructured":"Jiang D xun, Zhang M hua, Zhang Q, Chen Y shan, Ma W jing, Wu W peng, et al. Influence of gallic acid on porcine neutrophils phosphodiesterase 4, IL-6, TNF-\u03b1 and rat arthritis model. J Integr Agric [Internet]. Chinese Academy of Agricultural Sciences; 2015;14:758\u201364. Available from: https:\/\/doi.org\/10.1016\/S2095-3119(14)60824-8.","DOI":"10.1016\/S2095-3119(14)60824-8"},{"key":"9361_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.580593","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin Y, Luo T, Weng A, Huang X, Yao Y, Fu Z, et al. Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front Immunol. 2020;11:1\u201313.","journal-title":"Front Immunol"},{"key":"9361_CR50","doi-asserted-by":"publisher","unstructured":"Yoon CH, Chung SJ, Lee SW, Park YB, Lee SK, Park MC. Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Jt Bone Spine [Internet]. Elsevier Masson SAS; 2013;80:274\u20139. Available from: https:\/\/doi.org\/10.1016\/j.jbspin.2012.08.010.","DOI":"10.1016\/j.jbspin.2012.08.010"},{"key":"9361_CR51","first-page":"1","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Gao H, Chen C, Jia W, Xu D, Jiang G. IDO Inhibitor and gallic acid cross-linked small molecule drug synergistic treatment of melanoma. Front Oncol. 2022;12:1\u201311.","journal-title":"Front Oncol"},{"key":"9361_CR52","doi-asserted-by":"publisher","unstructured":"Chen HM, Wu YC, Chia YC, Chang FR, Hsu HK, Hsieh YC, et al. Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett [Internet]. Elsevier Ireland Ltd; 2009;286:161\u201371. Available from: https:\/\/doi.org\/10.1016\/j.canlet.2009.05.040.","DOI":"10.1016\/j.canlet.2009.05.040"},{"key":"9361_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4314\/tjpr.v18i3.4","volume":"18","author":"R Rajagopalan","year":"2019","unstructured":"Rajagopalan R, Jain SK, Trivedi P. Synergistic anti-cancer activity of combined 5-fuorouracil and gallic acid-stearylamine conjugate in a431 human squamous carcinoma cell line. Trop J Pharm Res. 2019;18:471\u20137.","journal-title":"Trop J Pharm Res"},{"key":"9361_CR54","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00894-011-1265-3","volume":"18","author":"DK Yadav","year":"2012","unstructured":"Yadav DK, Khan F, Negi AS. Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. J Mol Model. 2012;18:2513\u201325.","journal-title":"J Mol Model"},{"key":"9361_CR55","doi-asserted-by":"crossref","unstructured":"Calautti E, Avalle L, Poli V. Psoriasis: a STAT3-centric view. Int J Mol Sci. Switzerland; 2018;19.","DOI":"10.3390\/ijms19010171"},{"key":"9361_CR56","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/jid.2013.182","volume":"133","author":"RM Andr\u00e9s","year":"2013","unstructured":"Andr\u00e9s RM, Montesinos MC, Naval\u00f3n P, Pay\u00e1 M, Terencio CM. NF-\u03baB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH. J Invest Dermatol. 2013;133:2362\u201371.","journal-title":"J Invest Dermatol"},{"key":"9361_CR57","first-page":"1207","volume":"131","author":"S Shahrzad","year":"2001","unstructured":"Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr United States. 2001;131:1207\u201310.","journal-title":"J Nutr United States"},{"key":"9361_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/JAD-2009-1135","volume":"18","author":"MG Ferruzzi","year":"2009","unstructured":"Ferruzzi MG, Lobo JK, Janle EM, Cooper B, Simon JE, Wu Q-L, et al. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer\u2019s disease. J Alzheimers Dis. 2009;18:113\u201324.","journal-title":"J Alzheimers Dis"},{"key":"9361_CR59","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1208\/s12249-013-9991-8","volume":"14","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S, Ahammed SM, Saha BP, Mukherjee PK. The gallic acid-phospholipid complex improved the antioxidant potential of gallic acid by enhancing its bioavailability. AAPS PharmSciTech. 2013;14:1025\u201333.","journal-title":"AAPS PharmSciTech"},{"key":"9361_CR60","doi-asserted-by":"publisher","unstructured":"Variya BC, Bakrania AK, Madan P, Patel SS. Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice. Regul Toxicol Pharmacol [Internet]. Elsevier; 2019;101:71\u20138. Available from: https:\/\/doi.org\/10.1016\/j.yrtph.2018.11.010.","DOI":"10.1016\/j.yrtph.2018.11.010"},{"key":"9361_CR61","doi-asserted-by":"crossref","unstructured":"Niho N, Shibutani M, Tamura T, Toyoda K, Uneyama C, Takahashi N, et al. Subchronic toxicity study of gallic acid by oral administration in F344 rats. Food Chem Toxicol an Int J Publ Br Ind Biol Res Assoc. England; 2001;39:1063\u201370.","DOI":"10.1016\/S0278-6915(01)00054-0"},{"key":"9361_CR62","doi-asserted-by":"publisher","unstructured":"Li Y, Yang Q, Shi Z, Zhou M, Yan L, Li H, et al. The anti-inflammatory effect of Feiyangchangweiyan capsule and its main components on pelvic inflammatory disease in rats via the regulation of the NF-\u03baB and BAX\/BCL-2 pathway. Evidence-Based Complement Altern Med [Internet]. Hindawi; 2019;2019:9585727. Available from: https:\/\/doi.org\/10.1155\/2019\/9585727.","DOI":"10.1155\/2019\/9585727"},{"key":"9361_CR63","doi-asserted-by":"crossref","unstructured":"Variya BC, Bakrania AK, Madan P, Patel SS. Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice. Regul Toxicol Pharmacol [Internet]. 2019;101:71\u20138. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0273230018303027..","DOI":"10.1016\/j.yrtph.2018.11.010"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09361-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-023-09361-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09361-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T10:34:12Z","timestamp":1684233252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-023-09361-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9361"],"URL":"https:\/\/doi.org\/10.1007\/s12026-023-09361-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"28 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was conducted in accordance with the Declaration of Helsinki. Our study was thoroughly revised and conducted after approval by Ethics Committee of the University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece, was granted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}